These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11411800)
1. Inhibition of peristaltic activity by cannabinoids in the isolated distal colon of mouse. Mancinelli R; Fabrizi A; Del Monaco S; Azzena GB; Vargiu R; Colombo GC; Gessa GL Life Sci; 2001 May; 69(1):101-11. PubMed ID: 11411800 [TBL] [Abstract][Full Text] [Related]
2. SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity. Pan X; Ikeda SR; Lewis DL Mol Pharmacol; 1998 Dec; 54(6):1064-72. PubMed ID: 9855635 [TBL] [Abstract][Full Text] [Related]
3. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon. Mulè F; Amato A; Baldassano S; Serio R Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859 [TBL] [Abstract][Full Text] [Related]
4. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice. McMahon LR; Koek W Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon. Sibaev A; Yüce B; Kemmer M; Van Nassauw L; Broedl U; Allescher HD; Göke B; Timmermans JP; Storr M Am J Physiol Gastrointest Liver Physiol; 2009 Jan; 296(1):G119-28. PubMed ID: 19033531 [TBL] [Abstract][Full Text] [Related]
7. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. Gifford AN; Ashby CR J Pharmacol Exp Ther; 1996 Jun; 277(3):1431-6. PubMed ID: 8667207 [TBL] [Abstract][Full Text] [Related]
8. Antagonism between the anti-inflammatory activity of the cannabinoid WIN 55212-2 and SR 141716A. Pozzi O; Misiano P; Clark GD; Visentin L Pharmacology; 2003 Nov; 69(3):158-63. PubMed ID: 14512703 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments. Yousif MH; Oriowo MA Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656 [TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol. McMahon LR Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389 [TBL] [Abstract][Full Text] [Related]
11. Modulation of peristalsis by cannabinoid CB(1) ligands in the isolated guinea-pig ileum. Izzo AA; Mascolo N; Tonini M; Capasso F Br J Pharmacol; 2000 Mar; 129(5):984-90. PubMed ID: 10696099 [TBL] [Abstract][Full Text] [Related]
12. Effect of CB1 Ligands on Neurogenic and Myogenic Contractile Responses in the Guinea-Pig Ileum. Donnerer J; Liebmann I Pharmacology; 2018; 101(5-6):330-336. PubMed ID: 29627825 [TBL] [Abstract][Full Text] [Related]
13. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. Mulè F; Amato A; Baldassano S; Serio R Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103 [TBL] [Abstract][Full Text] [Related]
14. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human. Martin RS; Luong LA; Welsh NJ; Eglen RM; Martin GR; MacLennan SJ Br J Pharmacol; 2000 Apr; 129(8):1707-15. PubMed ID: 10780977 [TBL] [Abstract][Full Text] [Related]
15. Cannabinoid 1 receptors modulate intestinal sensory and motor function in rat. Yüce B; Kemmer M; Qian G; Müller M; Sibaev A; Li Y; Kreis ME; Storr M Neurogastroenterol Motil; 2010 Jun; 22(6):672-e205. PubMed ID: 20158615 [TBL] [Abstract][Full Text] [Related]
16. WIN-55,212-2 and SR-141716A alter nicotine-induced changes in locomotor activity, but do not alter nicotine-evoked [3H]dopamine release. Rodvelt KR; Bumgarner DM; Putnam WC; Miller DK Life Sci; 2007 Jan; 80(4):337-44. PubMed ID: 17067637 [TBL] [Abstract][Full Text] [Related]
17. Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices. Gifford AN; Tang Y; Gatley SJ; Volkow ND; Lan R; Makriyannis A Neurosci Lett; 1997 Nov; 238(1-2):84-6. PubMed ID: 9464661 [TBL] [Abstract][Full Text] [Related]
18. Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A. Gessa GL; Casu MA; Carta G; Mascia MS Eur J Pharmacol; 1998 Aug; 355(2-3):119-24. PubMed ID: 9760025 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells. Takahashi KA; Linden DJ J Neurophysiol; 2000 Mar; 83(3):1167-80. PubMed ID: 10712447 [TBL] [Abstract][Full Text] [Related]
20. Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice. Castañé A; Maldonado R; Valverde O Br J Pharmacol; 2004 Aug; 142(8):1309-17. PubMed ID: 15265804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]